ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,257, issued on May 13, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).
"Multispecific antigen-binding molecules and uses thereof" was invented by Julian Andreev (Sleepy Hollow, N.Y.), Nithya Thambi (Furlong, Pa.), Frank Delfino (Poughquag, N.Y.), Joel Martin (Putnam Valley, N.Y.), Gavin Thurston (Briarcliff Manor, N.Y.), Katherine Cygnar (New York) and Nicholas Papadopoulos (The Woodlands, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides multispecific antigen-binding molecules and uses thereof. The multispecific antigen-binding molecules comprise a first antigen-binding domain that specifically bi...